Corcept Therapeutics Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $129.1M | $8.1M | $-6.4M | $-31.4M | $-46.0M | $-38.0M | $-32.4M | $-26.0M |
| Depreciation & Amortization | $106.0K | $87.0K | $155.0K | $141.0K | $74.0K | $27.0K | $3.0K | $6.0K |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $13.4M | $7.1M | $6.0M | $5.2M | $5.2M | $5.3M | $3.4M | $2.1M |
| Net Cash from Operating Activities | $60.9M | $18.4M | $3.1M | $-27.4M | $-37.1M | $-36.0M | $-27.4M | $-22.3M |
| Investing Activities | ||||||||
| Capital Expenditures | $419.0K | $194.0K | $17.0K | $174.0K | $127.0K | $151.0K | $25.0K | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-73.5M | $-194.0K | — | — | $-127.0K | $-151.0K | $-25.0K | — |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | $0 | $0 | — | — | — | — | — | — |
| Net Cash from Financing Activities | $-8.0M | $-7.1M | — | — | $-970.0K | $89.6M | $42.5M | $23.0M |
| Net Change in Cash | $-20.5M | $11.1M | $16.2M | $-30.6M | $-38.2M | $53.4M | $15.1M | $711.0K |
| Free Cash Flow | $60.5M | $18.2M | $3.1M | $-27.6M | $-37.2M | $-36.2M | $-27.4M | — |